The study aims to test and evaluate a digital bladder cancer decision aid for in patients with bladder cancer before they start treatment. The intervention tool includes a range of animated and commented videos as well as questionnaires on the entire spectrum of bladder cancer treatment. The study will check if this decision aid can help reduce patients' decisional- and emotional stress as well as increase their understanding of their disease. It will also look at how easy the tool is to use. By showing that the decision aid works, the goal is to better prepare bladder cancer patients for making treatment decisions, boost their confidence and independence, and encourage them to be more involved in their healthcare decisions.
- Patients with high-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) before initiating definitive therapy - Patients with muscle-invasive urothelial carcinoma of the bladder before initiating definitive therapy - Consent to participate in the study - Ability to use a digital device (independently or at least with a relative)
- Patients unable to give consent - Patients under legal guardianship - Patients with low-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) - Patients with intermediate-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) - Patients with high-risk non-muscle invasive urothelial carcinoma of the bladder (according to EORTC classification) after initiating therapy - Patients with muscle-invasive urothelial carcinoma of the bladder after initiating therapy
Descisional conflict